Liquid Biopsy Shortens Time to NSCLC Treatment

Patients who underwent plasma ctDNA testing started therapy for advanced NSCLC earlier than those who underwent only tissue biopsy, but "plasma first does not mean plasma only," the authors say.

Related Keywords

Toronto ,Ontario ,Canada ,Neil Osterweil ,Miguel Garc ,Princess Margaret Cancer Centre ,Princess Margaret Cancer Foundation ,Division Of Medical Oncology Hematology Fellowship Award ,Inivata Inc ,Yale Cancer Center ,Smilow Cancer ,Lung Health Foundation Breathe Better Breathing ,One Grant Award Program ,Hematology Fellowship Award ,District Lung Cancer Innovation ,Lung Cancer ,Ung Carcinoma ,Ancer Lung ,Liquid Biopsy ,Luid Biopsy ,Luid Phase Biopsy ,Cancer Blood Test ,Ancer Saliva Test ,Lood Biopsy ,Erum Biopsy ,Non Small Cell Lung Cancer ,Nsclc ,Biopsy ,Genomics ,Genomic Medicine ,Edicine Genomic ,Tissue ,Small Cell Lung Cancer ,Biologic Therapy ,Cancer ,Alignant Neoplasia ,Arcinoma ,Targeted Therapy ,Plasma ,Leukemia ,Lung ,Dna Sequencing ,Blood ,